Erratum: Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease
Nature Medicine（2017）
摘要
Nat. Med.; 10.1038/nm.4307; corrected online 11 April 2017 In the version of this article initially published, there were two typographical errors in the Abstract. The unnecessary 'h' in the line “Furthermore, h according to.....” has been deleted. The line “OSM is thus a potential biomarker of and therapeutic target for IBD,.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要